Disclosed positions

Estimated from their latest filings — positions may have changed since

$4.98M

combined est. value

Stock	Shares	Price	Value	Weight	As of
IONSIONIS PHARMACEUTICALS INC	56,344	$64.27	$3.62M	73%	2026-02-11
CYTKCYTOKINETICS INC	15,784	$86.07	$1.36M	27%	2026-06-01

IONS

IONIS PHARMACEUTICALS INC

$3.62M

56,344 sh

CYTK

CYTOKINETICS INC

$1.36M

15,784 sh

All filings on record

Every Form 4 transaction we track for this filer

all 11buys 0sells 9

Stock	Transaction	Date	~6mo later
CYTKCYTOKINETICS INC	Sell $370.4K · 5,000 sh	2026-06-01	—
CYTKCYTOKINETICS INC	Grant — · 2,851 sh	2026-05-27	—
CYTKCYTOKINETICS INC	Sell $306.1K · 5,000 sh	2026-03-02	—
IONSIONIS PHARMACEUTICALS INC	Sell $413.6K · 5,000 sh	2026-02-11	—
CYTKCYTOKINETICS INC	Sell $323.6K · 5,000 sh	2025-11-19	—
IONSIONIS PHARMACEUTICALS INC	Sell $358.7K · 5,000 sh	2025-10-15	—
IONSIONIS PHARMACEUTICALS INC	Sell $476.3K · 9,250 sh	2025-09-02	—
IONSIONIS PHARMACEUTICALS INC	Sell $542.0K · 10,750 sh	2025-09-02	—
IONSIONIS PHARMACEUTICALS INC	Sell $17.1K · 400 sh	2025-08-06	—
IONSIONIS PHARMACEUTICALS INC	Sell $192.6K · 4,600 sh	2025-08-06	—
IONSIONIS PHARMACEUTICALS INC	Exercise — · 4,079 sh	2025-07-15	—

CYTKSell

2026-06-01 · CYTOKINETICS INC

$370.4K

—

CYTKGrant

2026-05-27 · CYTOKINETICS INC

2,851

—

CYTKSell

2026-03-02 · CYTOKINETICS INC

$306.1K

—

IONSSell

2026-02-11 · IONIS PHARMACEUTICALS INC

$413.6K

—

CYTKSell

2025-11-19 · CYTOKINETICS INC

$323.6K

—

IONSSell

2025-10-15 · IONIS PHARMACEUTICALS INC

$358.7K

—

IONSSell

2025-09-02 · IONIS PHARMACEUTICALS INC

$476.3K

—

IONSSell

2025-09-02 · IONIS PHARMACEUTICALS INC

$542.0K

—

IONSSell

2025-08-06 · IONIS PHARMACEUTICALS INC

$17.1K

—

IONSSell

2025-08-06 · IONIS PHARMACEUTICALS INC

$192.6K

—

IONSExercise

2025-07-15 · IONIS PHARMACEUTICALS INC

4,079

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.